Strategic Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Strategic Investment Advisors's BMY Position: Q2 2026 in Review
Strategic Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, buying an estimated $24.7K and bringing the position to 2,088 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #373.
Strategic Investment Advisors first reported a position in BMY in Q1 2019 and has held it in 18 quarters since. The position peaked at $917K in Q2 2021. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Strategic Investment Advisors held 2,088 shares of Bristol-Myers Squibb worth $120K as of Q2 2026.
- Strategic Investment Advisors bought 430 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.7K.
- Bristol-Myers Squibb made up 0.01% of Strategic Investment Advisors's portfolio in Q2 2026, its #373 holding.
- Strategic Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 18 quarters since.
- Strategic Investment Advisors's Bristol-Myers Squibb position peaked at $917K in Q2 2021.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Strategic Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.